Research

Is the future of drugs safe and non-addictive?

June 11, 2012 Drug abuse

In years to come alcohol may be replaced with happier alternatives and we could all be immunised against developing harmful habits   The next 20 years hold great opportunities for drugs research. We could see the development of pharmacological substitutes, agents to block the effects of drugs and help people break addictions, and drug-based aids […]

Continue Reading →

Ecstasy and cannabis should be freely available for study, says David Nutt

May 31, 2012 Cannabis

Former government adviser says regulations make it too difficult to research psychoactive drugs with potential medical uses Alok Jha, science correspondent The Guardian, Thursday 31 May 2012 Ecstasy and cannabis should be freely available for study. The classification system that makes drugs such as cannabis and MDMA (ecstasy) illegal has prevented scientists from properly researching their possible therapeutic […]

Continue Reading →

Pelosi criticizes Obama’s medical cannabis crackdown

May 10, 2012 Cannabis

Minority House of Representatives Leader Nancy Pelosi Condemns Obama Medical Marijuana Crackdown original article viastopthedrugwar.org Nancy Pelosi had Obama’s ear after he won the White House in 2008. Will he listen to her now? “I have strong concerns about the recent actions by the federal government that threaten the safe access of medicinal marijuana to […]

Continue Reading →

Finnish drug experts reveal 2020 forecast

May 10, 2012 Research

original article via Helsingin Sanomat A rare study of drug experts, conducted in Finland, has produced a forecast for drug use in Finland in 2020. The study was conducted by the Police College of Finland. It may also outline the future for drug use in similar political systems. More than half those surveyed predicted there […]

Continue Reading →

Imaging the brain on psychedelics – Dr. Robin Carhart-Harris

April 30, 2012 Research

Dr. Robin Carhart-Harris is one of the first researchers in 40 years to be allowed to investigate the effects of psychedelic drugs. In breakthrough research forming part of the Beckley Foundation / Imperial College Psychedelic Research Programme, he used an fMRI brain imager to study the resting state activation in the brains of volunteers how […]

Continue Reading →

Psilocybin’s effects on the brain and Aldous Huxley’s ‘reducing valve’ of consciousness: blog reaction to Beckley-Imperial Psilocybin research

January 27, 2012 LSD

In the popular science blog io9, Robert T. Gonzales ties up findings from this week’s Beckley Foundation-Imperial College Psilocybin paper in the PNAS with Aldous Huxley’s ‘reducing valve’ hypothesis, initially presented in his 1954 book The Doors of Perception (http://mescaline.com/huxley.htm); also, to more recent theorising by Karl Friston of University College London (http://www.fil.ion.ucl.ac.uk/~karl/), who postulates, in […]

Continue Reading →

Press Release: The Beckley Foundation-Imperial College Psychedelic Research Programme

January 26, 2012 Beckley Science in the Media

Press Release 25th January 2012 The Beckley Foundation-Imperial College Psychedelic Research Programme Surprising findings of Research: Potential therapeutic applications of psychedelic drugs fMRI brain scans show that psilocybin, the active ingredient in magic mushrooms, lowers the activity of specific brain regions. The finding contradicts the popular belief that psychedelic drugs increase brain activity, and has […]

Continue Reading →

Beckley Foundation-Imperial College collaboration publishes revolutionary research on effects of psilocybin on the brain

January 26, 2012 Press Releases

fMRI brain scans show that psilocybin, the active ingredient in magic mushrooms, lowers the activity of specific brain regions. The finding contradicts the popular belief that psychedelic drugs increase brain activity, and has far reaching implications for the therapeutic use of psilocybin in the treatment of depression and cluster headaches, as well as throwing light […]

Continue Reading →

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

January 3, 2012 BF Scientific Publications

The subjective effects of psychedelic drugs are caused by decreased activity and connectivity in the brain’s key connector hubs, enabling a state of unconstrained cognition.

Continue Reading →

Implications for psychedelic-assisted psychotherapy: a functional magnetic resonance imaging study with psilocybin

January 3, 2012 BF Scientific Publications

An observed switch in sensory function during recall from a pattern of deactivation under placebo to a pattern of activation under psilocybin may explain why memories can be felt as especially vivid or ‘real’ under psychedelics.

Continue Reading →
Thumbnail image for Review of Cannabis Policy: Moving Beyond Stalemate

Review of Cannabis Policy: Moving Beyond Stalemate

July 12, 2011 Beckley Press

A glowing review of the Beckley Foundation’s book “Cannabis Policy: Moving Beyond Stalemate” has been published in POP News (here), the newsletter for the Canadian Institute of Population and Public Health, one of 13 Institutues that comprise the Canadian Institutes of Health Research. The review was written by Dr Brian P Emerson This article reflects […]

Continue Reading →

MDMA for treating post traumatic stress disorder: 80% success rate. Beckley Foundation’s work on psilocybin also praised

July 8, 2011 Beckley Science in the Media

An article posted by Craig K. Comstock on the Huffington Post talks of the huge success of Michael Mithoefer’s study into the medicinal purposes of MDMA, in particular reference to treating post traumatic stress disorder (PTSD). After MDMA-assisted psychotherapy, 80% no longer met the diagnostic criteria for PTSD, as compared to only 25% in the […]

Continue Reading →
Thumbnail image for Johns Hopkins Study Probes “Sacred Mushroom” Chemical

Johns Hopkins Study Probes “Sacred Mushroom” Chemical

June 16, 2011 Worldwide Psychedelic Research

This is a brilliant new study from the team at Johns Hopkins University.  The Beckley Foundation is currently collaborating on another study with the team from Johns Hopkins, led by Professor Roland Griffiths, researching the effects of psilocybin as an aid to psychotherapy for treating nicotine addiction. The results so far have been extremely promising. […]

Continue Reading →
Thumbnail image for Psilocybin Reduces Blood Flow to the Brain

Psilocybin Reduces Blood Flow to the Brain

May 16, 2011 Psilocybin

Psychedelic drug users throughout the ages have described their experiences as mind-expanding. They might be surprised, therefore, to hear that psilocybin – the active ingredient in magic mushrooms – actually decreases blood flow as well as connectivity between important areas of the brain that control perception and cognition. The same areas can be over-active in […]

Continue Reading →

The Healing Effects of Ecstasy

May 16, 2011 Featured Slider

Curiouser and Curiouser: Could Ecstasy Actually Heal Brains as well as Minds? Beckley Foundation Scientific advisor and collaborator Professor David Nutt talks about an interesting new study (that has not received any media attention), which shows that MDMA (ecstasy) actually improves recovery from brain injury rather than worsening it. For 30 years we have had […]

Continue Reading →
Thumbnail image for Cannabis as a Substitute for Alcohol and Other Drugs

Cannabis as a Substitute for Alcohol and Other Drugs

February 23, 2011 Cannabis

A study by Amanda Reiman at University of California, Berkeley examined drug and alcohol use, and the occurrence of substitution among medical cannabis patients. Previous research in this field has suggested that medical cannabis patients might be using more alcohol than non patients, and might also have a higher instance of alcohol abuse than the […]

Continue Reading →
Thumbnail image for Ecstasy Does Not Wreck the Mind

Ecstasy Does Not Wreck the Mind

February 21, 2011 Featured Slider

The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide.  Past research has suggested that ecstasy users perform worse than non-users on some tests of mental ability.  But there are concerns that the methods used to conduct that research were flawed, and the experiments […]

Continue Reading →
Thumbnail image for Cannabis Use and Earlier Onset of Psychosis

Cannabis Use and Earlier Onset of Psychosis

February 16, 2011 Cannabis

Cannabis is the most widely used addictive substance after tobacco and alcohol. The 2009 National Survey on Drug Use and Health reported that more than 16 million Americans use cannabis on a regular basis, most of whom started using cannabis and other drugs during their teenage years. There is little doubt about the existence of an association […]

Continue Reading →

Effects of Cannabidiol on Schizophrenia-like Symptoms in People Who use Cannabis

February 11, 2011 Cannabis

Convergent evidence suggests a link between cannabis use and psychosis. However, cannabis comprises a combination of cannabinoids and these different constituents may have distinct effects, not all of which are detrimental to mental health. The main component of smoked cannabis is D9-tetrahydrocannabinol (D9-THC), which is thought to be responsible for the majority of the psychotomimetic […]

Continue Reading →

Cannabis – Recent Advances

February 11, 2011 Cannabis

Over the last 40 years, cannabinoid chemistry and pharmacology have been the object of thousands of publications. For obvious reasons, most attention has been paid to Cannabis. As cannabidiol (CBD; generally found in relatively high concentrations in Cannabis, several groups have also investigated the pharmacological activities of this component, although not to the extent that […]

Continue Reading →

Cannabis, the Mind and Society: The Hash Reality

February 11, 2011 Cannabis

The classical Greek term pharmakon indicates that a substance can be a remedy as well as a poison, and in many traditional societies cannabis was considered to have both of these properties. However, as the twentieth century progressed, cannabis gradually lost its status as a useful remedy, and fewer and fewer people regarded it as […]

Continue Reading →

Cannabidiol, A Cannabis Sativa

February 11, 2011 Cannabis

A high dose of A9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of A9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. […]

Continue Reading →

CANNABIDIOL INTERFERES WITH THE EFFECTS OF A9-TETRAHYDROCANNABINOL IN MAN

February 10, 2011 Cannabis

A9-THC) in laboratory animals, the present work was carried out to study possible interaction between CBD and A9-THC in human beings. In a double blind procedure, 40 healthy male volunteers were assigned to 1 of 8 experimental groups, receiving per oral route, placebo, 30 mg A9-THC, 15, 30 or 60 mg of CBD, and mixtures […]

Continue Reading →

Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders

February 9, 2011 Cannabis

Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa and belongs to the so-called ‘cannabinoids’ (CBs). This term refers to a heterogeneous family of molecules usually exhibiting pharmacological properties by interacting with specific receptors. So far, two membrane receptors for CBs, both coupled to G protein and named CB1 and […]

Continue Reading →

Cannabidiol For the Treatment of Psychosis in Parkinson’s Disease

February 9, 2011 Cannabis

The management of psychosis in Parkinson’s disease (PD) has been considered a great challenge for clinicians and there is a need for new pharmacological intervention. Previously an antipsychotic and neuroprotective effect of Cannabidiol (CBD) has been suggested. Therefore, the aim of the present study was to directly evaluate for the first time, the efficacy, tolerability […]

Continue Reading →

Antisychotic Effects of Cannabidiol

February 9, 2011 Cannabis

Background: In contrast to delta-9-tetrahydrocannabinol, the phytocannabinoid cannabidiol does not exert psychotomimetic effects. Cannabidiol was suggested a re-uptake inhibitor of anandamide and potential antipsychotic properties have been hypothesized for it. We therefore performed a clinical trial to investigate thesis hypothesis and to clarify the underlying link to the neurobiology of schizophrenia. Methods: We performed an […]

Continue Reading →
Thumbnail image for Experiences of Psilocybin in BF Study

Experiences of Psilocybin in BF Study

February 1, 2011 Featured Slider

Part of the Beckley Foundation/Imperial College Psychedelic Research Program In the worlds first study with psilocybin and fMRI the Beckley Foundation’s director Amanda Feilding, working with Professor David Nutt and Dr Carhart Harris, have investigated the effects of psilocybin on blood flow in the brain using fMRI to identify the functional brain correlates of the […]

Continue Reading →
Thumbnail image for The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

February 1, 2011 Research

After a pause of nearly 40 years in research by organization such as the Beckley Foundation into the effects of psychedelic drugs, recent advances in our understanding of the neurobiology of psychedelics, such as lysergic acid diethylamide (LSD), psilocybin and ketamine have led to renewed interest in the clinical potential of psychedelics in the treatment […]

Continue Reading →
Thumbnail image for History of Psychedelic Research in the United Kingdom

History of Psychedelic Research in the United Kingdom

February 1, 2011 Featured Video

This presentation by Dr. Ben Sessa is on the History of Psychedelic Research in the UK, with particular reference to the work of Dr Ronald Sandison and LSD treatment explored by the maverick psychiatrist Panel: Psychedelic Psychotherapy. This video is from the Psychedelic Science in the 21st Century, a conference in San Jose, California, April […]

Continue Reading →
Thumbnail image for Cannabis: What’s The Harm?

Cannabis: What’s The Harm?

January 31, 2011 Cannabis

In BBC3 documentary Cannabis: What’s the Harm, Ex-EastEnders star James Alexandrou, pictured, talks about his drug use for the first time and investigates the effects of Britain’s favourite illegal drug, from cannabis sold on the street to the hidden world of organised crime. After the newspapers published a photo of him with a joint in […]

Continue Reading →